Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Dec 19:13:79-102.
doi: 10.2147/DDDT.S186966. eCollection 2019.

Efficacy of neoadjuvant platinum-based chemotherapy during the second and third trimester of pregnancy in women with cervical cancer: an updated systematic review and meta-analysis

Yizuo Song  1 , Yi Liu  1 , Min Lin  1 , Bo Sheng  1 , Xueqiong Zhu  1
Affiliations
Meta-Analysis

Efficacy of neoadjuvant platinum-based chemotherapy during the second and third trimester of pregnancy in women with cervical cancer: an updated systematic review and meta-analysis

Yizuo Song et al. Drug Des Devel Ther. .

Abstract

Purpose: To evaluate the efficacy and safety of neoadjuvant platinum-based chemotherapy during pregnancy in women with cervical cancer.

Methods: The PubMed, Embase, and Cochrane Library databases were fully searched to find eligible studies regarding platinum use during pregnancy in women with cervical cancer from January 1980 to September 2018. Data were extracted from the selected studies independently by two authors. Descriptive statistics were calculated for categorical data (frequency and percentage) and numeration data (mean and SD for normally distributed data and median and range for abnormally distributed data). Survival analyses were performed using Kaplan-Meier survival curves and log-rank tests to estimate overall survival and progression-free survival for all patients.

Results: A total of 39 studies including 88 cervical cancer patients with platinum administration during pregnancy were selected in this meta-analysis, and 64 women provided International Federation of Gynecology and Obstetrics stage information. Among the latter, 56 of 64 (87.5%) were diagnosed with early stages (I and IIA) and the remaining 8 of 64 (12.5%) had advanced stages (IIB, III, and IV). In relation to cisplatin, 86 pregnant women were identified, whereas only 2 pregnant women with carboplatin application were retrieved. Overall, 88 newborns were delivered from 84 pregnancies, including two sets of twins and one set of triplets, among which 71 neonates (71 of 88, 80.7%) were completely healthy at birth. All children were healthy at the end of follow-up (median 17 months, range 0-149.5 months), except one who was diagnosed with retroperitoneal embryonal rhabdomyosarcoma at 5 years old and one who had acute myeloid leukemia at 22 months of age. At the end of follow-up (range 4.75-156 months), 16 of 81 (19.8%) patients were diagnosed with recurrence of cervical cancer, and 11 (90%) of those died because of cancer relapse. Neither median overall survival nor median progression-free survival were reached.

Conclusion: Our results demonstrated that neoadjuvant platinum-based chemotherapy could be a favorable choice for the management of patients with cervical cancer during the second and third trimesters. To reduce the side effects of chemotherapy, cisplatin might be good to use as monotherapy in these patients.

Keywords: cervical cancer; meta-analysis; neoadjuvant chemotherapy; platinum; pregnancy.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Flow diagram of study selection.
Figure 2
Figure 2
Kaplan–Meier overall survival curve.
Figure 3
Figure 3
Kaplan–Meier progression-free survival curve.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. De Vincenzo R, Tortorella L, Ricci C, et al. Locally advanced cervical cancer complicating pregnancy: a case of competing risks from the Catholic University of the Sacred Heart in Rome. Gynecol Oncol. 2018;150(3):398–405. - PubMed
    1. Kayahashi K, Mizumoto Y, Myojo S, Mitani Y, Tajima A, Fujiwara H. A successful case of neoadjuvant chemotherapy and radical hysterectomy during pregnancy for advanced uterine cervical cancer accompanied by neonatal erythroderma. J Obstet Gynaecol Res. 2018;44(10):2003–2007. - PubMed
    1. Ricci C, Scambia G, de Vincenzo R. Locally advanced cervical cancer in pregnancy: overcoming the challenge. A case series and review of the literature. Int J Gynecol Cancer. 2016;26(8):1490–1496. - PubMed
    1. Surbone A, Achtari C. Embryonal rhabdomyosarcoma in a child exposed to chemotherapy in utero: a mere coincidence? Eur J Obstet Gynecol Reprod Biol. 2016;207:235. - PubMed
    1. Köhler C, Oppelt P, Favero G, et al. How much platinum passes the placental barrier? Analysis of platinum applications in 21 patients with cervical cancer during pregnancy. Am J Obstet Gynecol. 2015;213(2):206.e1–5. - PubMed

MeSH terms